Xgeva OK'd for Rare Bone Tumor

(MedPage Today) -- SILVER SPRING, Md. -- The bone-active biologic drug denosumab (Xgeva) may be used to treat giant cell tumor of the bone when surgery is contraindicated, the FDA announced Thursday.

Source: MedPage Today Campaign '08 - June 13, 2013 Category: American Health Source Type: news